News (from Edinburgh Research and Innovation)

Licensed vaccine creates a major legacy for the University

30 July 2002

When Professor Ken Murray licensed his pioneering Hepatitis B vaccine to a US biotechnology company in the 1980s, no-one could have predicted the global impact of his discovery or the contribution that the royalty income would make to future education and research at the University.


We use cookies to help us make your experience on this website better. Please click the continue button to accept our cookies.
To learn more about what cookies are and how to manage them visit